Sort   by:  
 Page size 
UnknownEfficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular Schwannomas.
Not available
S-EPMC4872317 | biostudies-literature
UnknownSafety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.
Not available
S-EPMC3922714 | biostudies-literature
UnknownRetrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City.
Not available
S-EPMC7702220 | biostudies-literature
UnknownFollicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
Not available
S-EPMC9894575 | biostudies-literature
UnknownOutcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Not available
S-EPMC10278789 | biostudies-literature
UnknownDifferentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort.
Not available
S-EPMC11408082 | biostudies-literature
UnknownFinerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.
Not available
S-EPMC9862372 | biostudies-literature
UnknownReducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis.
Not available
S-EPMC9933165 | biostudies-literature
UnknownRisk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Not available
S-EPMC3266606 | biostudies-literature
UnknownCurrent whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.
Not available
S-EPMC5578359 | biostudies-literature
Sort   by:  
 Page size